|
Volumn 11, Issue 3, 2001, Pages 214-216
|
Pretransplant evaluation of a patient with acute intermittent porphyria
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
BARBITURIC ACID DERIVATIVE;
BUMETANIDE;
CALCINEURIN INHIBITOR;
CALCITRIOL;
CISATRACURIUM;
CYCLOSPORIN;
CYTOCHROME P450;
DOXAZOSIN;
ESMOLOL;
FENTANYL CITRATE;
GANCICLOVIR;
HEME;
HEMOGLOBIN;
LABETALOL;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PENTAMIDINE ISETHIONATE;
PORPHOBILINOGEN;
PORPHOBILINOGEN DEAMINASE;
POTASSIUM DIHYDROGEN PHOSPHATE;
PROPOFOL;
RANITIDINE;
STEROID;
SULFANILAMIDE DERIVATIVE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
UNINDEXED DRUG;
VANCOMYCIN;
ACUTE INTERMITTENT PORPHYRIA;
DRUG SAFETY;
HUMAN;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
NONHUMAN;
PREOPERATIVE PERIOD;
REVIEW;
SYMPTOMATOLOGY;
|
EID: 0034823031
PISSN: 15269248
EISSN: None
Source Type: Journal
DOI: 10.7182/prtr.11.3.61965k72uq73v0vx Document Type: Review |
Times cited : (7)
|
References (13)
|